Drug Resistance
New findings in drug resistance described from University of Mississippi
Published in Medical Patent Law Weekly, April 14th, 2010
Investigators publish new data in the report 'An update on the synthesis and antibacterial effects of carbapenems.' "The double-edged sword of antibiotic use in the fight against disease has saved countless lives at the cost of an escalation in pathogenic bacteria with increased resistance to multiple antibiotic classes. Reduction of resistance is a complicated multi-step endeavor that requires a sustained international effort of reduced utilization, infection control and development of effective and economical antimicrobial agents," scientists in the United States report.
"The carbapenems are beta-lactam antibiotics that are stable to most beta-lactamases. They have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Alnylam Pharmaceuticals, Inc.
Alnylam Announces Additional Grant of Tuschl II Patent in Japan - Alternatives to Laboratory Animals
Scientists at MatTek describe research in alternatives to laboratory animals - American College of Medical Genetics
American College of Medical Genetics Lauds Federal Court Ruling of - American Science and Engineering, Inc.
American Science and Engineering, Inc. Receives $3.0 Million Order from the Middle East for Multiple ZBVs - Antifungals
Data from Mississippi State University advance knowledge in antifungals - Antimicrobials
Investigators at University of Louisville zero in on antimicrobials - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
